More states announce lockdown as India sees record 4,187 COVID1-9 deaths, over 4 lakh cases in 24 hrs

-

Kerala and Tamil Nadu on Saturday joined the list of states imposing tougher restrictions in a bid to curb the exponential rise of COVID-19 cases. On the national front, India's numbers continued to be grim with a record 4,187 deaths in 24 hours.

A total of 4,01,078 new cases were reported during the same period, taking the caseload to 2,18,92,676.

The Kerala government imposed a complete lockdown from Saturday morning, while the newly-elected DMK government in Tamil Nadu announced a 15-day total shutdown from 10 May.

On Friday, Kerala chief minister Pinarayi Vijayan had tweeted that "no one will go hungry" during the nine-day lockdown and announced measures to provide food for people.

Tamil Nadu chief minister MK Stalin said that a total lockdown had to be clamped in the backdrop of a sharp increase in daily new infections of about 25,000 which was likely to go up.

"The total lockdown will be enforced from 4 am on 10 May to 4 am on 24 May to further intensify the efforts to curb the spread of the disease," he said. Other southern states including Karnataka, Andhra Pradesh, Telangana and Puducherry are also either already under lockdown or are gearing up for lockdown restrictions.

Meanwhile, in a bid to streamline the availability of medical oxygen at a time when the entire country is facing a severe shortage of the crucial resource, the Supreme Court constituted a 12-member National Task Force (NTF) to formulate a methodology for allocation of oxygen to states and Union Territories.

A bench of Justices DY Chandrachud and MR Shah said that the Union Cabinet Secretary will be the convenor of the national task force and may nominate an officer not below the rank of Additional Secretary to depute for him, when necessary.

"The establishment of this Task Force will enable the decision makers to have inputs which go beyond finding ad-hoc solutions to the present problems. The likely future course of the pandemic must be taken into contemplation at the present time," the bench said.

The Centre also sought to boost the availability of a new anti-COVID-19 drug on Saturday. An anti-COVID oral drug developed by the DRDO was approved by the Drugs Controller General of India (DCGI) for emergency use as an adjunct therapy in moderate to severe coronavirus patients, the defence ministry said.

"In the ongoing second COVID-19 wave, a large number of patients are facing severe oxygen dependency and need hospitalisation. The drug is expected to save precious lives due to the mechanism of operation of the drug in infected cells. This also reduces the hospital stay of COVID-19 patients," the ministry said.

The Union Defence Ministry said that clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

The approval to the drug, developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL) in Hyderabad, has come at a time when India has been grappling with a record-breaking wave of coronavirus pandemic that has stretched the country's healthcare infrastructure to its limit.

 

Twelve states account for 80.68% of India's active cases, shows data

Twelve states accounted for 80.68 percent of India's over 37.23 lakh active coronavirus cases, PTI reported quoting official data.

Maharashtra has the maximum number of active cases at 6.57 lakh, followed by Karnataka 5,36,661, Kerala 4,02,997, Uttar Pradesh 2,54,118, and Rajasthan 1,99,147 cases.

The other states having large active cases are Andhra Pradesh, Gujarat, Tamil Nadu, Chhattisgarh, West Bengal, Haryana and Bihar.

Ten states accounted for 70.77 percent of the new cases in the last 24 hours, out of which Maharashtra has reported the highest daily new cases at 54,022, followed by Karnataka 48,781 and Kerala 38,460 new cases.

Among the remaining seven states and union territories with high daily new cases are Uttar Pradesh (27,763), Tamil Nadu (26,465) and Delhi (19,832).

Arvind Kejriwal demands 2.6 cr vaccine doses for inoculation of all in Delhi in next three months

Delhi chief minister Arvind Kejriwal on Saturday said the number of COVID-19 vaccination centres will be increased three times in Delhi and demanded that the Centre supply of around 2.6 crore vaccine doses for inoculation of all people in the National Capital in the next three months.

Currently, vaccination is going on at 100 centres in Delhi. The number of centres will be increased to 250-300 by the Delhi government, he said in an online briefing.

In order to vaccinate all people in Delhi, over three crore doses will be required, out of which around 40 lakh have already been received, he said. The chief minister urged the Centre to provide it 85 lakh doses per month so that all the Delhiites could be vaccinated in the next three months.

He said that due to good arrangements in Delhi, people from NCR towns like Noida, Ghaziabad were also reaching here to get the vaccines.

So, Delhi will require a little more than three crore doses, he said.

"Roughly 1.5 crore people are above 18 years of age. We need three crore vaccine doses to vaccinate these 1.5 crore people, but we've received just 40 lakh doses. As a result, we need 2 crore 60 lakh additional vaccines," he said.

State-wise restrictions to curb second wave

With COVID-19 cases continuing to rise across India, several more states either imposed stricter restrictions or extended the existing ones.

Rajasthan has decided to implement a 15-day strict lockdown in the state from 10 to 24 May though curbs continue to be in place since last month.

 

In Maharashtra, where lockdown-like curbs were imposed on 5 April coupled with prohibitory orders and restrictions on the movement of people. The curbs were later extended till 15 May. In Latur district, the lcoal administration imposed a six-day lockdown starin from today.

Goa, which lifted a four-day lockdown on Monday, except in tourist hotspots like Calangute and Candolim in North Goa, will undergo a 16-day curfew from tomorrow (9 May).

In the northeast, Manipur 10-day imposed curfew in seven districts starting from today till 17 May. Himachal Pradesh had imposed lockdown or "corona curfew" in the state on Friday till 16 May.

While in the south, Kerala imposed a complete lockdown from today with over 25,000 cops on the street to enforce restrictions, the state of Tamil Nadu will undergo a 15-day total lockdown from 10 May.

COVID-19 caseload details

Registering a steady increase, active cases have reached 37,23,446 which comprise 17.01 percent of the total infections, while the national COVID-19 recovery rate has dropped to 81.90 percent, the Union Health Ministry's data showed.

The number of people who have recuperated from the disease surged to 1,79,30,960, while the case fatality rate was recorded at 1.09 percent, the data stated.

According to the Indian Council of Medical Research, 30,04,10,043 samples have been tested up to 7 May, with 18,08,344 being tested on Friday.

The 4,187 new fatalities include 898 from Maharashtra, 592 from Karnataka, 372 from Uttar Pradesh, 341 from Delhi, 208 from Chhattisgarh, 197 from Tamil Nadu, 165 from Punjab, 164 from Rajasthan, 162 from Haryana, 137 from Uttarakhand, 136 from Jharkhand, 119 from Gujarat and 112 from West Bengal.

Of the 2,38,270 deaths reported in the country so far, 74,413 were from Maharashtra, 18,739 from Delhi, 17,804 from Karnataka, 15,171 from Tamil Nadu, 14,873 from Uttar Pradesh, 12,076 from West Bengal, 10,158 from Chhattisgarh and 10,144 from Punjab.

With inputs from PTI



from Firstpost India Latest News https://ift.tt/3esEQYH
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more